A Systematic Framework for Drug Repositioning from Integrated Omics and Drug Phenotype Profiles Using Pathway-Drug Network

<div>Validated drugs. Candidate drugs with successful results for both the biological validation and computational evaluation are considered repositioned drugs for breast cancer.</div>

BioMed Research International

fig9

Figure 9

Figure 9: A Systematic Framework for Drug Repositioning from Integrated Omics and Drug Phenotype Profiles Using Pathway-Drug Network 